GBGB9911059.5A
GB9911059D0
(en)
|
1999-05-12 |
1999-05-12 |
Organic compounds
|
PL99346764A
PL194069B1
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-ht4
|
IDW20010318A
ID28510A
(en)
|
1998-08-21 |
1999-08-19 |
NEW ORAL FORMULATION FOR AGONISTS OR 5-HT4 ANTAGONISTS
|
TR2004/00187T
TR200400187T2
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation.
|
SK243-2001A
SK285255B6
(en)
|
1998-08-21 |
1999-08-19 |
Solid peroral pharmaceutical composition and use thereof
|
BR9913135-8A
BR9913135A
(en)
|
1998-08-21 |
1999-08-19 |
Oral formulation
|
JP2000565848A
JP4048024B2
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation
|
CZ20010619A
CZ300647B6
(en)
|
1998-08-21 |
1999-08-19 |
Solid pharmaceutical composition for peroral administration comprising tegaserod or pharmaceutically acceptable salt thereof
|
PCT/EP1999/006083
WO2000010526A2
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-ht4 agonists or antagonists
|
TR2001/00361T
TR200100361T2
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation
|
EP99942892A
EP1104289B1
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-ht4 agonists or antagonists
|
AT99942892T
ATE316782T1
(en)
|
1998-08-21 |
1999-08-19 |
NEW ORAL FORMULATIONS FOR 5-HT4 AGONISTS OR ANTAGONISTS
|
CNB998099244A
CN1165293C
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-HT4 agonists or antagonists
|
NZ509832A
NZ509832A
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-HT4 agonists or antagonists
|
CA002338794A
CA2338794C
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-ht4 agonists or antagonists
|
DE69929703T
DE69929703T2
(en)
|
1998-08-21 |
1999-08-19 |
NEW ORAL FORMULATIONS FOR 5-HT4 AGONISTS OR ANTAGONISTS
|
RU2001106999/15A
RU2260424C9
(en)
|
1998-08-21 |
1999-08-19 |
New composition for oral administration
|
KR10-2001-7002161A
KR100529659B1
(en)
|
1998-08-21 |
1999-08-19 |
New Oral Formulation for 5-HT4 Agonists or Antagonists
|
IL14123699A
IL141236A0
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulations for 5-ht4 agonists or antagonists
|
EEP200100104A
EE05054B1
(en)
|
1998-08-21 |
1999-08-19 |
Oral pharmaceutical composition of a 5-HT4 agonist or antagonist and its use in medicine
|
IT1999MI001826A
IT1314185B1
(en)
|
1998-08-21 |
1999-08-19 |
PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF SUBSTANCES ACTIVELY SOLUBLE IN AQUEOUS MEDIA
|
ES99942892T
ES2257869T3
(en)
|
1998-08-21 |
1999-08-19 |
NEW ORAL FORMULATION FOR AGONISTS OR ANTAGONISTS OF 5-HT4.
|
TR2001/02259T
TR200102259T2
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation
|
YUP-87/01A
RS50104B
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-th4 agonists or antagonists
|
CNA2004100638733A
CN1589906A
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-HT4 agonists or antagonists
|
DK99942892T
DK1104289T3
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulations for 5-HT 4 agonists or antagonists
|
AU56232/99A
AU762829B2
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-HT4 agonists or antagonists
|
HU0103431A
HU228179B1
(en)
|
1998-08-21 |
1999-08-19 |
Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
|
PL380173A
PL200132B1
(en)
|
1998-08-21 |
1999-08-19 |
Application of 3-(5-methoxy-1H-indole-3-methylene)-N-pentyl carbazyl imidoamide
|
SI9930892T
SI1104289T1
(en)
|
1998-08-21 |
1999-08-19 |
New oral formulation for 5-ht4 agonists or antagonists
|
FR9910666A
FR2782454B1
(en)
|
1998-08-21 |
1999-08-20 |
SOLID ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN ACID SENSITIVE AGENT AND / OR LITTLE SOLUBLE IN AQUEOUS MEDIUM AND A DEAGRANGER, AND THE USE OF SAID COMPOSITION
|
FR9914897A
FR2784899B1
(en)
|
1998-08-21 |
1999-11-26 |
AGONIST, PARTIAL AGONIST OR ANTAGONIST OF THE 5-HT4 RECEPTOR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION, INCLUDING FOR VETERINARY USE
|
IS5851A
IS2369B
(en)
|
1998-08-21 |
2000-02-20 |
New oral 5-HT4 agonist or oral antagonist
|
FR0010748A
FR2799123B1
(en)
|
1998-08-21 |
2000-08-21 |
SOLID ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN ACID SENSITIVE AND / OR LITTLE SOLUBLE AGENT IN AN AQUEOUS MEDIUM AND A DISAGREGENT, AND USE OF THE COMPOSITION
|
BG105257A
BG65322B1
(en)
|
1998-08-21 |
2001-02-14 |
Oral formulation for 5-ht4 agonists or antagonists
|
NO20010863A
NO328756B1
(en)
|
1998-08-21 |
2001-02-20 |
Oral formulations for 3- (5-methoxy-1H-indol-3yl-methylene) -N-pentylcarbazimidamide and use thereof
|
HR20010123A
HRP20010123B1
(en)
|
1998-08-21 |
2001-02-20 |
New oral formulation 5-ht4 agonists or antagonists
|
HK01107619A
HK1038179A1
(en)
|
1998-08-21 |
2001-10-31 |
New oral formulation for 5-ht4 agonists or antagonists
|
US10/620,178
US20030236183A1
(en)
|
1998-08-21 |
2003-07-15 |
Oral formulation
|
AU2003248212A
AU2003248212A1
(en)
|
1998-08-21 |
2003-09-22 |
New oral formulation for 5-HT4 agonists or antagonists
|
AU2006200048A
AU2006200048A1
(en)
|
1998-08-21 |
2006-01-06 |
New oral formulation for 5-HT4 agonists or antagonists
|
US11/947,769
US20080075773A1
(en)
|
1998-08-21 |
2007-11-29 |
New Oral Formulation
|
AU2009200403A
AU2009200403A1
(en)
|
1998-08-21 |
2009-02-04 |
New oral formulation for 5-HT4 agonists or antagonists
|
US13/303,459
US20120071537A1
(en)
|
1998-08-21 |
2011-11-23 |
New Oral Formulation
|
US13/755,444
US20130158092A1
(en)
|
1998-08-21 |
2013-01-31 |
New Oral Formulation
|